NewsRoom Articles - Page 164 of 591

TuesdayJul 05, 2022 11:15 am

Flora Growth Corp.’s (NASDAQ: FLGC) Management Confident in the Company’s Short, Medium, and Long-Term Growth Prospects

Flora just announced the repurchase of $5 million of its outstanding common shares This repurchase aligns with its overall global expansion plan, and its move to grow its market reach These moves by Flora assure shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so On June 16, 2022, Flora Growth (NASDAQ: FLGC) announced that its Board of Directors had authorized the repurchase of up to $5 million of its outstanding common shares. This came in the wake of the expiration of a one-year lockup period for specific shareholders who had acquired shares before…

TuesdayJul 05, 2022 9:15 am

Cilicon’s Partner Program Accelerates Enterprise Innovation and Product ROI via Diversifying Transformation

Cilicon, the leading, globally trusted, product solution provider of cannabis vape technology and manufacturing, announces the launch of its Cilicon Partner Program, a flexible, collaborative distributor partnership to help cannabis vaporizer enterprises expand product selections, upgrade product performance, expedite product delivery cycles and reduce product inventory costs. Cilicon today began accepting cannabis vape hardware distributors of different regions, sizes, levels and needs to further expand the supply market for cannabis vaporizers. The Cilicon Partner Program uses a one-to-one approach to achieve diversification and benefits maximization to help distributors satisfy consumers’ demands in seeking more diversified and humanized products and services,…

TuesdayJul 05, 2022 4:20 am

420 with CNW — Trial Suggests Marijuana Could Replace Opioids in Pain Management

As more states have opted to end cannabis prohibition and launch legal cannabis markets, there has been a growing body of literature indicating that the controversial plant can be effective against a variety of medical issues. Several studies have found that marijuana can be used to treat chronic pain, and plenty of people are already using the controversial plant as an alternative to pharmaceutical pain medications. Now researchers currently working on a clinical trial to see whether cannabis can be used as an alternative to opioids in pain management have revealed that the pilot phase had “very promising” results. Run…

FridayJul 01, 2022 4:20 pm

420 with CNW — American Medical Association Approves Measure on Expungement of Cannabis Records

Millions of Americans across the country with cannabis-related offenses on their records may soon have the offenses expunged after the largest professional association of physicians in the United States passed a resolution in favor of expunging marijuana-related offenses. Last week, the American Medical Association (AMA) announced that it had passed a measure that would require states that have either decriminalized or legalized cannabis to expunge marijuana-related arrests and convictions that are now considered legal. The association made this announcement at its annual House Delegates meeting in Chicago, stating that it had already formally adopted this change in policy. A statement…

FridayJul 01, 2022 4:20 am

420 with CNW — New Congressional Measure Will Enable Cannabis Companies to List on Stock Exchanges

A pair of congressmen has introduced a bipartisan bill that seeks to allow cannabis companies to be listed on national stock exchanges. The bill would also grant the industry access to crucial financial services like banking, solving an issue that has plagued the industry since its inception. Rep. Guy Reschenthaler and Rep. Troy Carter are the cosponsors of the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act. Filed last week, the legislation seeks to allow cannabis and ancillary businesses to access financial services such as checking accounts, cashless payments and loans, something federal law prohibits by threatening action against…

ThursdayJun 30, 2022 4:20 pm

420 with CNW — House Panel Asks Military to Reconsider Cannabis Penalties for Soldiers

Federal law prohibits American servicemembers from consuming cannabis. A 2018 notice declares that although dozens of states have legalized cannabis for medical or recreational purposes, federal law restricts military members from using cannabis, CBD (cannabidiol), any cannabinoid derivatives and THC-infused products. The notice also states that the ingestion of hemp and hemp-seed derivatives was prohibited because they could contain trace amounts of THC. This is despite the fact that studies have shown cannabis can be efficient in alleviating conditions such as, depression, chronic pain, insomnia and post-traumatic stress disorder (PTSD), which are common among military veterans. A key House panel…

ThursdayJun 30, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Anticipates Continued Growth for Cannabis Operations Under New Colombian Administration

Flora Growth is a cannabis cultivator and distributor with a base of operations in Colombia’s fertile growing climate, capable of feeding the company’s expanding international supply chain Colombia has undergone a number of regulatory changes in recent years as it emerges from the shadows of years-long drug wars and embraces a growing global acceptance of cannabis products The South American country voted in a new presidential administration in June, and Flora Growth is applauding the president-elect’s continued openness to international cannabis trade Flora Growth announced significant revenue growth during its year-end financial reporting in May, and the company stated it…

ThursdayJun 30, 2022 4:20 am

420 with CNW — Congressional Leaders Seek to Give Indian Tribes Cannabis Protections

Several congressional leaders are looking to include language that would protect Native American tribes from being penalized by the federal government for legalizing cannabis within their territories in a variety of funding bills. In 2014, the federal government stated that tribes were allowed to grow and sell cannabis as long as they followed the same federal guidelines set for states that had legalized cannabis. The lawmakers now want it codified into law that the federal government cannot persecute Indian tribes that legalize cannabis within their territories. More specifically, the new cannabis provision would forbid federal funds appropriated to agencies within…

WednesdayJun 29, 2022 4:20 pm

420 with CNW — Vehicle Insurance Data Suggests Medical Cannabis Legalization Reduces Drunk Driving

A new study has revealed that contrary to what many prohibitionists feared, medical cannabis legalization in the country has not led to an uptick in rates of intoxicated driving. In fact, the research has found that states with medical marijuana programs have seen a reduction in drunk-driving rates, adding to the growing body of research showing that there is a link between cannabis reform and a reduced risk of drunk driving. Published in the latest issue of the journal “Health Economics,” the study analyzed auto insurance premium data from 2014 to 2019. Researchers discovered that premiums in states with legal…

WednesdayJun 29, 2022 11:15 am

New Agreements Signed Between Lexaria Bioscience Corp. (NASDAQ: LEXX) and BevNology LLC; Pre-IND Meeting Request Filed with FDA

The two companies signed a manufacturing operating agreement and a commercial agreement Lexaria sent a pre-IND meeting request letter to the US FDA and plans to file the full IND application in late 2022/early 2023 The FDA has acknowledged Lexaria's pre-IND request and responded with conditions prior to the target date of July 30, 2022 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has recently announced signing two agreements with BevNology LLC, the product and development arm of InterContinental Beverage Capital (“IBC”), operating its state-of-the-art lab and manufacturing facility just outside of Atlanta, Georgia. This announcement only…

News and publishing service for cannabis related companies

Contact us: 512.354.7000